Biggest News Aggregation in the World
📰 Rom News

Page 476 - Rom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.

Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial

Bagsværd, Denmark, 22 May 2023 – Novo Nordisk today announced headline results from OASIS 1, a phase 3a trial in the global OASIS programme. OASIS 1 is a 68-week, efficacy and safety trial... | May 22, 2023
Martin Holst Lange Novo Nordisk Development At Novo Nordisk York Stock Exchange Nasdaq Copenhagen New York Stock Exchange

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

- Following treatment, the N-acetylaspartate levels of CANaspire participants are consistent with levels seen in individuals with milder Canavan disease based on findings from the Company’s... | May 22, 2023
United States Genevieve Laforet Florian Eichler Bio Pharma Inc Bridgebio Pharma Inc Drug Administration

MyJournals.org - Science - 'IJMS, Vol. 24, Pages 9063: Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines' (International Journal of Molecular Sciences)

MyJournals.org - Science - IJMS, Vol. 24, Pages 9063: Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines (International Journal of Molecular Sciences)
Placenta International Journal Of Molecular Sciences From Bench International Journal Molecular Sciences Ligand Binding Mechanical Factors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science